CRDF FY 2018 Earnings — Cardiff Oncology, Inc. Revenue & Financial Results | Market Cap Arena

CRDFCardiff Oncology, Inc.

$133M

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$378,000-25.1% YoY

Gross Profit

-$219,000-57.9% margin

Operating Income

-$17M-4511.4% margin

Net Income

-$16M-4354.8% margin

EPS (Diluted)

$-7.06

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$14M

Total Liabilities

$4M

Stockholders' Equity

$10M

Cash & Equivalents

$11M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$378,000	$505,000	-25.1%
Gross Profit	-$219,000	-$1M	+83.2%
Operating Income	-$17M	-$26M	+33.4%
Net Income	-$16M	-$25M	+33.9%